Holen Sie sich die Stockscreener-App
2.95
1.03%
0.03
Finanzdaten der Gt Biopharma Inc-Aktie (GTBP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Selling, General, and Administrative
|
27.77%
2.314
|
1.811 | 1.758 | 1.526 | 2.015 |
| Operating Income/Loss |
2.43%
-3.091
|
-3.168 | -3.122 | -3.621 | -3.665 |
| Nonoperating Income/Loss |
300.49%
0.825
|
0.206 | 0.706 | 1.629 | 3.438 |
| Income/Loss From Continuing Operations Before Tax |
23.50%
-2.266
|
-2.962 | -2.416 | -1.992 | -0.227 |
| Income/Loss From Continuing Operations After Tax |
23.50%
-2.266
|
-2.962 | -2.416 | -1.992 | -0.227 |
|
Net Income/Loss
|
23.50%
-2.266
|
-2.962 | -2.416 | -1.992 | -0.227 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
103.56%
1.3806
|
-38.75 | 41.02 | 40.17 | 39.09 |
| Diluted Average Shares |
103.56%
1.3806
|
-38.75 | 41.02 | 40.17 | -0.5405 |
| Basic Earnings Per Share |
70.29%
-1.64
|
-5.52 | -0.06 | -0.05 | -0.01 |
| Diluted Earnings Per Share |
70.29%
-1.64
|
-5.52 | -0.06 | -0.05 | -0.010 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):